Target intelligence / Profile preview

Carbonic Anhydrase IV Isoenzyme (CA IV)

Target
CA IV
Molecular classification
Enzyme, Zinc metalloenzyme, Carbonic anhydrase, GPI-anchored protein
01

Overview

Carbonic anhydrase IV (CA IV) is a membrane-associated isozyme of the carbonic anhydrase family that catalyzes the reversible hydration of carbon dioxide. It is anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor. CA IV is expressed predominantly on the luminal surfaces of pulmonary capillaries, proximal renal tubules, and capillary endothelial cells in various tissues. It facilitates gas exchange in the lungs and acid-base balance in the kidneys. Mutations in CA IV are linked to retinitis pigmentosa type 17 (RP17), and inhibitors like acetazolamide and brinzolamide are used therapeutically, particularly in glaucoma treatment.

Other names
Carbonic anhydrase 4CA4
02

Mechanism of action

Sulfonamides (e.g., acetazolamide, brinzolamide) bind directly within the active site, inhibiting the enzyme's catalytic activity.

03

Biological functions

CatalysisCarbon dioxide hydrationBicarbonate dehydrationGas exchangeAcid-base balanceCalcificationBone resorptionFormation/maintenance of fluids (aqueous humor, cerebrospinal fluid)
04

Disease associations

Retinitis Pigmentosa Type 17 (RP17)Glaucoma
05

Safety considerations

Inhibition can disrupt acid-base balance.Potential for off-target effects due to carbonic anhydrase family similarity.
06

Interacting drugs

Acetazolamide

1 more in the full profile.

Beyond the preview

Go deeper on Carbonic Anhydrase IV Isoenzyme (CA IV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbonic Anhydrase IV Isoenzyme (CA IV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call